117 related articles for article (PubMed ID: 8995949)
1. Improved localizing method of radiopill in measurement of entire gastrointestinal pH profiles: colonic luminal pH in normal subjects and patients with Crohn's disease.
Sasaki Y; Hada R; Nakajima H; Fukuda S; Munakata A
Am J Gastroenterol; 1997 Jan; 92(1):114-8. PubMed ID: 8995949
[TBL] [Abstract][Full Text] [Related]
2. [Levels of cytokines in mucosal biopsies of Crohn's colitis. Physiopatological observations].
Marongiu L; Scintu F; Melis MV; Pisano M; Zorcolo L; Capra F; Casula G
Minerva Chir; 2002 Feb; 57(1):35-40. PubMed ID: 11832856
[TBL] [Abstract][Full Text] [Related]
3. Increased gastric and intestinal permeability in patients with Crohn's disease.
Wyatt J; Oberhuber G; Pongratz S; Püspök A; Moser G; Novacek G; Lochs H; Vogelsang H
Am J Gastroenterol; 1997 Oct; 92(10):1891-6. PubMed ID: 9382060
[TBL] [Abstract][Full Text] [Related]
4. Acute lower gastrointestinal bleeding in Crohn's disease: characteristics of a unique series of 34 patients. Belgian IBD Research Group.
Belaiche J; Louis E; D'Haens G; Cabooter M; Naegels S; De Vos M; Fontaine F; Schurmans P; Baert F; De Reuck M; Fiasse R; Holvoet J; Schmit A; Van Outryve M
Am J Gastroenterol; 1999 Aug; 94(8):2177-81. PubMed ID: 10445546
[TBL] [Abstract][Full Text] [Related]
5. Gender-related differences in the clinical course of Crohn's disease.
Wagtmans MJ; Verspaget HW; Lamers CB; van Hogezand RA
Am J Gastroenterol; 2001 May; 96(5):1541-6. PubMed ID: 11374696
[TBL] [Abstract][Full Text] [Related]
6. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
7. Altered subjective appetite parameters in Crohn's disease patients.
Bannerman E; Davidson I; Conway C; Culley D; Aldhous MC; Ghosh S
Clin Nutr; 2001 Oct; 20(5):399-405. PubMed ID: 11534934
[TBL] [Abstract][Full Text] [Related]
8. Effect of disease localization on the anthropometric and metabolic features of Crohn's disease.
Capristo E; Addolorato G; Mingrone G; Greco AV; Gasbarrini G
Am J Gastroenterol; 1998 Dec; 93(12):2411-9. PubMed ID: 9860401
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
10. Clinical aspects of Crohn's disease of the upper gastrointestinal tract: a comparison with distal Crohn's disease.
Wagtmans MJ; Verspaget HW; Lamers CB; van Hogezand RA
Am J Gastroenterol; 1997 Sep; 92(9):1467-71. PubMed ID: 9317064
[TBL] [Abstract][Full Text] [Related]
11. Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers.
Devani M; Cugno M; Vecchi M; Ferrero S; Di Berardino F; Avesani EC; de Franchis R; Colman RW
Am J Gastroenterol; 2002 Aug; 97(8):2026-32. PubMed ID: 12190172
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of patients examined by capsule endoscopy for suspected small bowel Crohn's disease.
Girelli CM; Porta P; Malacrida V; Barzaghi F; Rocca F
Dig Liver Dis; 2007 Feb; 39(2):148-54. PubMed ID: 17196893
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.
Hlavaty T; Pierik M; Henckaerts L; Ferrante M; Joossens S; van Schuerbeek N; Noman M; Rutgeerts P; Vermeire S
Aliment Pharmacol Ther; 2005 Oct; 22(7):613-26. PubMed ID: 16181301
[TBL] [Abstract][Full Text] [Related]
14. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.
Wehkamp J; Schmid M; Fellermann K; Stange EF
J Leukoc Biol; 2005 Apr; 77(4):460-5. PubMed ID: 15618294
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome after ileocecal resection for Crohn's disease.
Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K; Chen SH
Am Surg; 1997 Jul; 63(7):627-33. PubMed ID: 9202538
[TBL] [Abstract][Full Text] [Related]
16. Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group.
Caesar I; Gross V; Roth M; Andus T; Schmidt C; Raedsch R; Weber A; Gierend M; Ewe K; Schölmerich J
Hepatogastroenterology; 1997; 44(14):445-51. PubMed ID: 9164517
[TBL] [Abstract][Full Text] [Related]
17. Significance of diminished factor XIII in Crohn's disease.
Chamouard P; Grunebaum L; Wiesel ML; Sibilia J; Coumaros G; Wittersheim C; Baumann R; Cazenave JP
Am J Gastroenterol; 1998 Apr; 93(4):610-4. PubMed ID: 9576457
[TBL] [Abstract][Full Text] [Related]
18. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
[TBL] [Abstract][Full Text] [Related]
19. Role of electrogastrography in detecting motility disorders in children affected by chronic intestinal pseudo-obstruction and Crohn's disease.
Bracci F; Iacobelli BD; Papadatou B; Ferretti F; Lucchetti MC; Cianchi D; Francalanci P; Ponticelli A
Eur J Pediatr Surg; 2003 Feb; 13(1):31-4. PubMed ID: 12664412
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic yield of wireless capsule enteroscopy in comparison with computed tomography enteroclysis.
Voderholzer WA; Ortner M; Rogalla P; Beinhölzl J; Lochs H
Endoscopy; 2003 Dec; 35(12):1009-14. PubMed ID: 14648412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
